References
- Stone RM. AML: current landscape and future directions. Hematology (Am Soc Hematol Educ Progam). Hematology 2004:98–117.
- Pazdur R, Coia LR, Hoskins WJ. Acute leukemias. CMP Healthcare Media, Oncology Publishing Group, 2004:747–772.
- B.AlarconD.GilP.DelgadoW.W.SchamelInitiation of TCR signaling: regulation within CD3 dimersImmunol Rev19120033846
- Goldsby RA, Kindt TJ, Osborne BA, Kuby J. in: Freeman WH (editor) Immunology. 5th ed. 2003.
- D.J.LenschowT.L.WalunasJ.A.BluestoneCD28/B7 system of T cell costimulationAnnu Rev Immunol141996233258
- R.J.GreenwaldG.J.FreemanA.H.SharpeThe B7 family revisitedAnnu Rev Immunol232005515548
- C.OrabonaU.GrohmannM.L.Belladonnaet alCD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86Nat Immunol5200411341142
- U.GrohmannC.OrabonaF.Fallarinoet alCTLA-4-Ig regulates tryptophan catabolism in vivoNat Immunol3200210971101
- P.S.LinsleyJ.L.GreeneW.Bradyet alHuman B7–1 and B7–2 bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptorsImmunity11994793801
- E.C.GuinanJ.G.GribbenG.J.Freemanet alPivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunityBlood84199432613282
- Z.Razi-WolfG.J.FreemanF.Galvinet alExpression and function of the murine B7 antigen. The major costimulatory molecule expressed by peritoneal exudates cellsProc Natl Acad Sci USA89199242104214
- K.InabaM.Witmer-PackM.Inabaet alThe tissue distribution of the B7–2 costimulator in mice. abundant expression on dendritic cells in situ and during maturation in vitroJ Exp Med180199418491860
- H.ReiserE.E.SchneebergerExpression and function of B7–1 and B7–2 in hapten-induced contact sensitivityEur J Immunol261996880885
- L.L.LanierS.O’FallonC.Somozaet alCD80, CD86 provide similar costimulatory signals for T cell proliferation, cytokine production, generation of CTLJ Immunol154199597
- A.N.SchweitzerF.BorrielloR.C.WongA.K.Abbaset alRole of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86J Immunol15819972713
- G.J.FreemanV.A.BoussiotisA.Anumanthanet alB7–1, B7–2 do not deliver identical costimulatory signalsImmunity21995523
- U.MatulonisC.DosiouG.Freemanet alB7-1 is superior to B7-2 cosstimulation in the induction and maintenance of T cell mediated antileukemia immunityJ Immunol15619961126
- G.BoulougourisJ.D.McleodY.I.Patelet alPositive and negative regulation of human T cell activation mediated by the CTLA-4/CD28 ligand CD80J Immunol16119983919
- M.InobeN.AokiP.S.Linsleyet alThe role of the B7–1a molecule, an alternatively spliced form of murine B7–1, on T cell activationJ Immunol1571996582
- J.G.ChaiS.VendettiE.AmofahJ.DysonR.LechlerCD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation deficient antigen presentationJ Immunol16520003037
- D.J.LenschowT.L.WalunasJ.A.BluestoneCD28/B7 system of T cell costimulationAnnu Rev Immunol141996233
- E.A.GreenfieK.A.NguyenV.K.KuchrooCD28/B7 costimulation: a reviewCrit. Rev. Immunol.181998389
- B.D.HockM.DraysonW.N.Pattonet alCirculating levels, clinical significance of soluble CD86 in myeloma patientsBr J Haematol1332006165
- A.MaedaK.YamamotoK.Yamashitaet alThe expression of co-stimulatory molecules and their relationship to the prognosis of human acute myeloid leukaemia: poor prognosis of B7–2-positive leukaemiaBr J Haematol102199812571262
- R.T.CostelloF.MalletD.SaintyD.MaraninchiJ.A.GastautD.OliveRegulation of CD80/B7–1 and CD86/B7–2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognitionEur J Immunol28199890103
- A.WhitewayT.CorbettR.AndersonI.MacdonaldH.G.PrenticeExpression of co-stimulatory molecules on acute myeloid leukaemia blasts may effect duration of first remissionBr J Haematol1202003442451
- H.TamuraK.TamadaK.Nakamuraet alExpression of functional B7–H2 and B7.2 co-stimulatory molecules and their prognostic implications in de novo acute myeloid leukemiaClinical Cancer Res11200557085717
- B.D.HockJ.L.MckenzieW.N.Pattonet alThe clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndromeCancer98200316811688
- B.D.HockW.N.PattonS.Budhiaet alHuman plasma contains a soluble form of CD86 which is present at elevated levels in some leukemia patientsLeukemia162002865873
- P.JeanninG.MagistrelliJ.P.Aubrryet alSoluble CD86 is a costimulatory molecule for human T lymphocytesImmunity1332000303312
- P.HollsbergC.ScholzD.E.Andersenet alExpression of a hypoglycosylated form of CD86 on human T cells with altered binding properties to CD28 and CTLA-4J Immunol159199747994805
- E.K.KapsogeorgouH.M.MoutsopoulosManoussakis Mn. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the Cd28 receptor, but has reduced binding to CTLA-4J Immunol166200131073113
- R.E.BrouwerJ.HoefnagelB.Borger van Der Burget alExpression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukemiaBr J Haematol1152001298308
- M.l.HeaneyD.W.GoldeSoluble cytokine receptorsBlood871996847857
- A.MaedaK.YamamotoK.Yamashitaet alThe expression of co-stimulatory molecules and their relationship to the prognosis of human acute myeloid leukaemia: poor prognosis of B7–2-positive leukaemiaBr J Haematol102199812571262
- H.TamuraK.TamadaK.Nakamuraet alExpression of functional B7–H2 and B7.2 co-stimulatory molecules and their prognostic implications in de novo acute myeloid leukemiaClinical Cancer Res11200557085717